Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Action modulators |
Mechanism Bacteria replacements, Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 1 | United Kingdom | ![]() | 12 Mar 2022 |